This study of Humira will be conducted to clarify the following with regard to the treatment of juvenile idiopathic arthritis affecting multiple joints with this drug:

  • Unknown adverse drug reactions (especially important adverse drug reactions)
  • Incidence and conditions of occurrence of adverse reactions in the clinical setting
  • Factors that may affect the safety and effectiveness of Humira

Read more: http://www.clinicaltrials.gov/ct2/show/NCT01412021?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30